Differential Activation of the Transcription Factor IRF1 Underlies the Distinct Immune Responses Elicited by Type I and Type III Interferons
- 1 September 2019
- journal article
- research article
- Published by Elsevier BV in Immunity
- Vol. 51 (3), 451-464.e6
- https://doi.org/10.1016/j.immuni.2019.07.007
Abstract
No abstract availableFunding Information
- Frederick National Laboratory for Cancer Research
- NIH (HHSN261200800001E)
- Intramural Research Program
- NIH
- Frederick National Lab
- Center for Cancer Research
This publication has 63 references indexed in Scilit:
- Generation of Mouse Small Intestinal Epithelial Cell Lines That Allow the Analysis of Specific Innate Immune FunctionsPLOS ONE, 2013
- A diverse range of gene products are effectors of the type I interferon antiviral responseNature, 2011
- CXCR3 ligands: redundant, collaborative and antagonistic functionsImmunology & Cell Biology, 2011
- Lambda Interferon Is the Predominant Interferon Induced by Influenza A Virus Infection In VivoJournal of Virology, 2010
- TNF and IFN Synergistically Enhance Transcriptional Activation of CXCL10 in Human Airway Smooth Muscle Cells via STAT-1, NF- B, and the Transcriptional Coactivator CREB-binding ProteinJournal of Biological Chemistry, 2010
- Genetic variation in IL28B and spontaneous clearance of hepatitis C virusNature, 2009
- Ligand-independent pathway that controls stability of interferon alpha receptorBiochemical and Biophysical Research Communications, 2008
- Type III Interferon (IFN) Induces a Type I IFN-Like Response in a Restricted Subset of Cells through Signaling Pathways Involving both the Jak-STAT Pathway and the Mitogen-Activated Protein KinasesJournal of Virology, 2007
- Id2 leaves the chromatin of the E2F4–p130-controlled c-myc promoter during hepatocyte priming for liver regenerationBiochemical Journal, 2006
- Human airway epithelial cells produce IP-10 (CXCL10) in vitro and in vivo upon rhinovirus infectionAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2005